Osteoporosis and Neurogenic bladder

Summary:

Neurogenic bladder is found among people with Osteoporosis, especially for people who are female, 60+ old.

The study analyzes which people have Neurogenic bladder with Osteoporosis. It is created by eHealthMe based on reports of 93 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteoporosis?

Osteoporosis (bones weak and more likely to break) is found to be associated with 1,814 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.

What is Neurogenic bladder?

Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion) is found to be associated with 471 drugs and 569 conditions by eHealthMe. Check the latest studies of Neurogenic bladder.

On Jul, 10, 2026

93 people who have Osteoporosis and Neurogenic Bladder are studied.

Would you have Neurogenic bladder when you have Osteoporosis?

Gender of people who have Osteoporosis and experienced Neurogenic Bladder *:

female: 91.76 %
male: 8.24 %

Age of people who have Osteoporosis and experienced Neurogenic Bladder *:

Common co-existing conditions for these people *:

Osteopenia (a condition where bone mineral density is lower than normal): 21 people, 22.58%
Pain: 11 people, 11.83%
High Blood Pressure: 10 people, 10.75%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 8 people, 8.60%
High Blood Cholesterol: 8 people, 8.60%
Organising Pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue): 8 people, 8.60%
Type 1 Diabetes: 6 people, 6.45%
Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 6.45%
Breast Cancer Stage Ii: 5 people, 5.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.38%

Common drugs taken by these people *:

Common symptoms for these people *:

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 64 people, 68.82%
Urinary Tract Infection: 55 people, 59.14%
Stress And Anxiety: 52 people, 55.91%
Fall: 50 people, 53.76%
Femur Fracture: 41 people, 44.09%
High Blood Pressure: 40 people, 43.01%
Dental Caries: 39 people, 41.94%
Depression: 35 people, 37.63%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 35 people, 37.63%
Urinary Retention (the inability to completely or partially empty the bladder): 33 people, 35.48%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Neurogenic bladder?

- Check whether Neurogenic bladder is associated with a drug or a condition

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .

Related studies:

Treatments, associated drugs and conditions:

Osteoporosis (290,734 reports)
Neurogenic bladder (4,810 reports)

All the drugs that are associated with Neurogenic bladder:

Neurogenic bladder (471 drugs)

All the conditions that are associated with Neurogenic bladder:

Neurogenic bladder (569 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Neurogenic bladder and Osteoporosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.